Impact Of Physical Activity On Metabolic Dysfunction Associated Steatohepatitis Patients: A Scoping Review
DOI:
https://doi.org/10.52783/jns.v14.2788Keywords:
Metabolic dysfunction associated steatohepatitis, physical activity, exercise therapy, liver disease, aerobic exerciseAbstract
Background: Metabolic Dysfunction Associated Steatohepatitis is a progressive liver condition characterized by excessive liver fat, inflammation, and fibrosis, which can lead to cirrhosis, liver failure, and liver cancer.
Methods: A Systematic search was conducted in PubMed, Scopus, GoogleScholar, and PeDro by using Boolean search with keywords. Studies from 1972 to 2025 were included. Selection criteria required studies to be peer-reviewed and focus on exercise interventions in MASH patients. Exclusion criteria included studies involving animals, non-interventional research, non-English publications, and conference abstracts. The PRISMA approach guided the selection process, and data were analyzed based on exercise type, duration, intensity, and effects on liver function and metabolic markers.
Results: Ten studies were included, in which aerobic and resistance exercise that reduces liver fat, improves insulin sensitivity, and decrease systemic inflammation. Moderate-to-vigorous intensity exercise for at least 150 minutes per week was associated with liver health improvements, even without weight loss. However, inconsistencies in study methodologies and participant characteristics led to mixed findings.
Conclusion: Physical activity plays an important role in managing MASH, offering benefits for liver function and metabolic health. The lack of standardized exercise protocols underscores the need for further research. Future studies should focus on long-term randomized controlled trials to refine exercise recommendations and assess their impact on disease progression.
Downloads
Metrics
References
Kang SH, Lee HW, Yoo JJ, Cho Y, Kim SU, Lee TH, Jang BK, Kim SG, Ahn SB, Kim H, Jun DW. KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clinical and molecular hepatology. 2021 Jun 22;27(3):363. Available from: https://doi.org/10.3350/cmh.2021.0145
Muthiah MD, Cheng Han N, Sanyal AJ. A clinical overview of non-alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications. Diabetes Obes Metab. 2022;24 (Suppl 2):3-14. Available from: https://doi.org/10.1111/dom.14452
Iqbal U, Perumpail BJ, Akhtar D, Kim D, Ahmed A. Physical activity is associated with nonalcoholic fatty liver disease and significant fibrosis measured by FibroScan. Clin Gastroenterol Hepatol. 2022;20(6):e1438-55. Available from: https://doi.org/10.1016/j.cgh.2021.10.003
Anstee QM, Mantovani A, Tilg H, Targher G. Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2018;15(7):425–439. Available from: https://doi.org/10.1038/s41575-018-0010-0
Jung JY, Kim D, Joo SK, Lee KS, Kim BG. Effect of non-alcoholic fatty liver disease on left ventricular diastolic function and geometry in the Korean general population. Hepatol Res. 2017;47(6):522–532. Available from: https://doi.org/10.1111/hepr.12878
El Hadi H, Di Vincenzo A, Vettor R, Rossato M. Relationship between heart disease and liver disease: A two-way street. Cells. 2020;9(3):567. Available from: https://doi.org/10.3390/cells9030567
Anstee QM, Day CP. The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2. Thieme Medical Publishers; 2015.
Tarantino G, Savastano S, Colao A. Hepatic steatosis, low-grade chronic inflammation, and hormone/growth factor/adipokine imbalance. World J Gastroenterol. 2010;16:4773-4783. Available from: https://doi.org/10.3748/wjg.v16.i38.4773
Moctezuma-Velázquez C. Current treatment for non-alcoholic fatty liver disease. Rev Gastroenterol Mex (Engl Ed). 2018;83:125-133. Available from: https://doi.org/10.1016/j.rgmx.2018.02.004
Hashida R, Kawaguchi T, Bekki M, Omoto M, et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review. J Hepatol. 2017;66:142–152. Available from: https://doi.org/10.1016/j.jhep.2016.08.023
Bacchi E, Negri C, Targher G, et al. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial). Hepatology. 2013;58:1287–95. Available from: https://doi.org/10.1002/hep.26474
Hallsworth K, Fattakhova G, Hollingsworth KG, et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut. 2011;60:1278–83. Available from: https://doi.org/10.1136/gut.2011.242073
Romero-Gómez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity, and exercise. J Hepatol. 2017;67:829-846. Available from: https://doi.org/10.1016/j.jhep.2017.05.016
Fernández T, Viñuela M, Vidal C, Barrera F. Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. PLoS One. 2022;17:e0263931. Available from: https://doi.org/10.1371/journal.pone.0263931
Yabe Y, Kim T, Oh S, Shida T, Oshida N, Hasegawa H, et al. Relationships of dietary habits and physical activity status with non-alcoholic fatty liver disease featuring advanced fibrosis. Int J Environ Res Public Health. 2021;18(17):8918. Available from: https://doi.org/10.3390/ijerph18178918
Oh S, Shida T, Yamagishi K, et al. Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: A retrospective study. Hepatology. 2015;61:1205–15. Available from: https://doi.org/10.1002/hep.27695
Hallsworth K, Adams LA. Lifestyle modification in NAFLD/NASH: Facts and figures. J Hepatol. 2019;70(2):331-333. doi:10.1016/j.jhepr.2019.10.008.
Hashida R, Kawaguchi T, Bekki M, Omoto M, Matsuse H, Nago T, et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review. J Hepatol. 2017;66(1):142-152. doi:10.1016/j.jhep.2016.08.023.
Keating SE, Hackett DA, George J, Johnson NA. Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis. J Hepatol. 2012;57(1):157-166. doi:10.1016/j.jhep.2012.02.023.
Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis R, Schwimmer JB. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol. 2011;106(3):460-468. doi:10.1038/ajg.2010.488.
O’Sullivan CJ, Hynes N, Mahendran B, Andrews EJ, Avalos G, Tawfik S. The role of exercise in the prevention and management of NAFLD: A review of the evidence. World J Hepatol. 2012;4(7):271-278. doi:10.4254/wjh.v4.i7.270.
Bacchi E, Negri C, Targher G, Faccioli N, Lanza M, Zoppini G, et al. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 randomized trial). Hepatology. 2013;58(4):1287-1295. doi:10.1002/hep.26393.
Smart NA, King N, McFarlane JR, Graham PL, Dieberg G. Effect of exercise training on liver function in adults who are overweight or exhibit fatty liver disease: A systematic review and meta-analysis. J Hepatol. 2018;69(1):416-423. doi:10.1016/j.jhep.2018.03.009.
Cuthbertson DJ, Breen L, Davies K, et al. Exercise improves surrogate measures of liver histological response in metabolic dysfunction-associated steatotic liver disease. Liver Int. 2024;44(1):123-134. doi:10.1111/liv.15947.
Is Metabolic-Associated Steatohepatitis (MASH) Reversible? What You Should Know. Health.com. Published March 17, 2025. Available from: https://www.health.com/is-mash-reversible-11687519.
What To Know About Metabolic Dysfunction-Associated Steatohepatitis (MASH). Health.com. Published March 14, 2025. Available from: https://www.health.com/metabolic-dysfunction-associated-steatohepatitis-11688748.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
